Polyneuropathy and vasculitis associated with IgG type I Cryoglobulinemia can be treated effectively with the anti-CD20 monoclonal antibody (Rituximab).

被引：0
|
作者：
Rosenthal, E [1 ]
Pesce, A [1 ]
Karsenti, JM [1 ]
Allieri-Rosenthal, MA [1 ]
Cassuto, JP [1 ]
机构：
[1] Archet 1 Hosp, Nice, France
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4914
引用
收藏
页码：292B / 292B
页数：1
相关论文
共 50 条
  • [41] Ofatumumab: a novel monoclonal anti-CD20 antibody
    Lin, Thomas S.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 51 - 59
  • [42] Severe idiopathic erythroblastic synartesis: successful treatment with the anti-CD20 monoclonal antibody rituximab
    Papakonstantinou, Georgios
    Loeffler, Helmut
    Haferlach, Torsten
    Brugger, Wolfram
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (06) : 547 - 549
  • [43] Treatment of thrombocytopenia in refractory Evan's syndrome with anti-CD20 monoclonal antibody (Rituximab).
    Baltathakis, I
    Kakkas, I
    Karkatitaris, C
    Papasavvas, PL
    Tsionos, K
    BLOOD, 2002, 100 (11) : 82B - 82B
  • [44] Anti-CD20 monoclonal antibody/thalidomideMyeloproliferative disorder in an elderly patient (first report with anti-CD20 monoclonal antibody): case report
    Reactions Weekly, 2001, 855 (1) : 7 - 7
  • [45] Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): Five cases
    Antonucci, Angela
    Negosanti, Massimino
    Tabanelli, Michela
    Varotti, Claudio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (03) : 178 - 183
  • [46] Successful Treatment of EBV PTLD with CNS Lymphomas with the Monoclonal Anti-CD20 Antibody Rituximab
    Kordelas, Lambros
    Trenschel, Rudolf
    Koldehoff, Michael
    Elmaagacli, Ahmet
    Beelen, Dietrich W.
    ONKOLOGIE, 2008, 31 (12): : 691 - 693
  • [47] Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-cd20 monoclonal antibody rituximab
    Swords, R
    Nolan, A
    Fay, M
    Quinn, J
    O'Donnell, R
    Murphy, PT
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (01): : 57 - 59
  • [48] A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia
    Saleh, MN
    Gutheil, J
    Moore, M
    Bunch, PW
    Butler, J
    Kunkel, L
    Grillo-López, AJ
    LoBuglio, AF
    SEMINARS IN ONCOLOGY, 2000, 27 (06) : 99 - 103
  • [49] Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (Rituximab)
    Kong, HH
    Prose, NS
    Ware, RE
    Hall, RP
    PEDIATRIC DERMATOLOGY, 2005, 22 (05) : 461 - 464
  • [50] Anti-CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis
    Korhonen, Riku
    Moilanen, Eeva
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (01) : 13 - 21
12345